|
Orchid Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
3963.70 Cr.
|
P/BV
|
3.11
|
Book Value (Rs.)
|
251.16
|
|
52 Week High/Low (Rs.)
|
1984/604
|
FV/ML
|
10/1
|
P/E(X)
|
39.78
|
|
Bookclosure
|
09/08/2023
|
EPS (Rs.)
|
19.65
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 19.65 | 19.06 | 11.35 | -0.48 | -28.55 |
| Diluted EPS (Rs.) | 19.65 | 19.06 | 11.35 | -0.48 | -28.55 |
| Cash EPS (Rs.) | 25.69 | 25.30 | 25.30 | 21.71 | -1.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 249.86 | 230.58 | 168.72 | 158.61 | 159.96 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 249.86 | 230.58 | 168.72 | 158.61 | 159.96 |
| Revenue From Operations / Share (Rs.) | 181.77 | 161.55 | 163.14 | 137.09 | 110.26 |
| PBDIT / Share (Rs.) | 28.52 | 27.91 | 25.25 | 15.22 | 15.93 |
| PBIT / Share (Rs.) | 21.71 | 21.35 | 11.82 | -6.10 | -10.76 |
| PBT / Share (Rs.) | 18.84 | 18.13 | 13.54 | -13.94 | -23.34 |
| Net Profit / Share (Rs.) | 18.88 | 18.74 | 11.88 | 0.38 | -28.55 |
| NP After MI And SOA / Share (Rs.) | 19.65 | 18.17 | 11.35 | -0.47 | -28.55 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 15.69 | 17.27 | 15.47 | 11.10 | 14.44 |
| PBIT Margin (%) | 11.94 | 13.21 | 7.24 | -4.44 | -9.75 |
| PBT Margin (%) | 10.36 | 11.22 | 8.29 | -10.16 | -21.16 |
| Net Profit Margin (%) | 10.38 | 11.60 | 7.27 | 0.28 | -25.89 |
| NP After MI And SOA Margin (%) | 10.80 | 11.24 | 6.95 | -0.34 | -25.89 |
| Return on Networth / Equity (%) | 7.86 | 7.88 | 6.72 | -0.30 | -17.84 |
| Return on Capital Employeed (%) | 7.85 | 8.37 | 5.65 | -2.86 | -4.00 |
| Return On Assets (%) | 5.90 | 5.93 | 3.78 | -0.17 | -9.41 |
| Long Term Debt / Equity (X) | 0.10 | 0.10 | 0.21 | 0.32 | 0.65 |
| Total Debt / Equity (X) | 0.13 | 0.11 | 0.48 | 0.41 | 0.65 |
| Asset Turnover Ratio (%) | 0.56 | 0.58 | 0.57 | 0.47 | 0.30 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.83 | 3.04 | 1.35 | 1.87 | 3.87 |
| Quick Ratio (X) | 1.68 | 2.03 | 0.73 | 1.15 | 2.79 |
| Inventory Turnover Ratio (X) | 3.12 | 2.14 | 2.02 | 2.09 | 1.60 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 9.95 | 8.65 | 3.20 | 1.94 | 1.27 |
| Interest Coverage Ratio (Post Tax) (%) | 7.59 | 6.81 | 1.50 | -0.77 | -0.85 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 3934.97 | 5169.07 | 1869.70 | 1420.30 | 10472.28 |
| EV / Net Operating Revenue (X) | 4.27 | 6.31 | 2.81 | 2.54 | 23.27 |
| EV / EBITDA (X) | 27.20 | 36.52 | 18.14 | 22.86 | 161.10 |
| MarketCap / Net Operating Revenue (X) | 4.27 | 6.47 | 2.36 | 2.07 | 22.36 |
| Price / BV (X) | 3.11 | 4.53 | 2.28 | 1.79 | 15.41 |
| Price / Net Operating Revenue (X) | 4.27 | 6.47 | 2.36 | 2.07 | 22.36 |
| EarningsYield | 0.02 | 0.01 | 0.02 | 0.00 | -0.01 |
